The Riverside Company Acquires HealthTech BioActives (HTBA) from Ferrer

Miura Partners Acquires HTBA (HealthTech BioActives)

November 5, 2024

Biotechnology

Miura Partners has signed an agreement to acquire HTBA (HealthTech BioActives), a Barcelona-headquartered producer of flavonoids and active vitamin B12 used across pharmaceutical, nutraceutical, food & beverage and animal nutrition markets. Miura will pursue organic and inorganic initiatives to consolidate HTBA as a leading platform for natural ingredients; the deal is the third investment from Miura Fund IV and is pending approval from the Spanish regulator.

The Riverside Company Acquires Controlling Stake in BioDue S.p.A

November 16, 2022

Pharmaceuticals

The Riverside Company has signed a definitive agreement to acquire a controlling stake in BioDue S.p.A, an Italian developer and manufacturer of dietary supplements, medical devices and cosmetics. Riverside plans to pursue a pan‑European buy‑and‑build strategy to expand BioDue's product range and commercial reach, while supporting operational improvements across its production sites.

The Riverside Company Invests in HemaTerra Technologies

April 18, 2019

Cloud & SaaS

The Riverside Company has invested in HemaTerra Technologies, a provider of cloud-based SaaS solutions for blood and plasma collection centers, hospitals and related healthcare organizations. Riverside said it will invest in product development, sales and marketing, and strategic partnerships to scale HemaTerra's offerings and support continued growth.

The Riverside Company Invests in Champion Healthcare Technologies and Combines It with HemaTerra

June 6, 2019

Cloud & SaaS

The Riverside Company has invested in Champion Healthcare Technologies and combined it with HemaTerra Technologies (a company Riverside invested in earlier) to form a leading medical specialty software business. The combined firm will provide SaaS solutions for implant lifecycle management and blood/plasma collection operations, serving over 500 hospitals and numerous independent blood and plasma centers across the United States.

The Riverside Company Invests in Western Botanicals

February 12, 2026

Food & Beverage

The Riverside Company has made a growth investment in Western Botanicals, a Spanish Fork, Utah-based contract development and manufacturing organization (CDMO) of vitamins, minerals and supplements. Riverside will partner with management — which retains a meaningful ownership stake — to support organic growth, expand product and format capabilities, and pursue an M&A strategy to broaden Western Botanicals' capabilities.

The Riverside Company Acquires ESHA Research

March 8, 2022

Cloud & SaaS

The Riverside Company, a global private equity firm, has acquired ESHA Research, a Salem, Oregon–based provider of SaaS nutritional analysis, label-compliance and formulation software. Riverside plans to invest in product innovation, sales and marketing, and customer support to accelerate product development, expand internationally, and pursue complementary add-on opportunities while ESHA continues to operate under its existing management and location.